Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Lantern Pharma Inc (LTRN)

Lantern Pharma Inc (LTRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Pancreatic Cancer Battle Intensifies: Biotech Innovations Aim to Boost Survival Rates Newswire.ca - Thu May 23, 10:51AM CDT

/CNW/ -- USA News Group – Known as one of the deadliest cancers, researchers are working diligently to help increase the chance of survival for pancreatic...

ONCY : 0.9541 (-2.64%)
CADL : 5.04 (+21.89%)
AZN : 65.63 (+2.13%)
MRUS : 45.49 (+2.56%)
LTRN : 3.08 (+4.41%)
ONC.TO : 1.33 (-2.92%)
Biotech Developers Pioneer New Treatments, Aiming to Reduce Pancreatic Cancer Fatalities in 2024 BayStreet.ca - Thu May 23, 8:32AM CDT

USA News Group – Known as one of the deadliest cancers, researchers are working diligently to help increase the chance of survival for pancreatic cancer patients through earlier detection, as according...

ONCY : 0.9541 (-2.64%)
ONC.TO : 1.33 (-2.92%)
CADL : 5.04 (+21.89%)
AZN : 65.63 (+2.13%)
MRUS : 45.49 (+2.56%)
LTRN : 3.08 (+4.41%)
Software Segment of Global A.I. Healthcare Billion Dollar Market Expected to Have Fastest Growth FinancialNewsMedia - Wed Apr 10, 7:45AM CDT

EQNX::TICKER_START (OTCQB:TREIF),(CSE:TRUE),(NYSE:MDT),(NASDAQ:NVDA),(NASDAQ:LTRN),(OTCQX:HWAIF),(TSX:AIDX) EQNX::TICKER_END

TREIF : 0.4075 (+7.35%)
TRUE.CN : 0.5700 (unch)
NVDA : 141.95 (-3.22%)
HWAIF : 1.0900 (-1.80%)
AIDX.TO : 1.56 (+0.65%)
LTRN : 3.08 (+4.41%)
MDT : 86.21 (+1.73%)
Global A.I. Medical Diagnostics Market Poised To Reach $3.7 Billion By 2028 FinancialNewsMedia - Wed Mar 20, 8:00AM CDT

EQNX::TICKER_START (OTCQB:TREIF),(CSE:TRUE),(OTCQX:HWAIF),(OTCQB:VRSSF),(NYSE:PATH),(NASDAQ:LTRN) EQNX::TICKER_END

VERS.NE : 0.3900 (+2.63%)
TREIF : 0.4075 (+7.35%)
TRUE.CN : 0.5700 (unch)
HWAIF : 1.0900 (-1.80%)
AIDX.TO : 1.56 (+0.65%)
VRSSF : 0.2795 (+9.61%)
VERS : 45.59 (+2.15%)
PATH : 14.24 (+4.09%)
LTRN : 3.08 (+4.41%)
Global A.I. Medical Diagnostics Market Poised To Reach $3.7 Billion By 2028 GlobeNewswire - Wed Mar 20, 8:00AM CDT

TREIF : 0.4075 (+7.35%)
TRUE.CN : 0.5700 (unch)
HWAIF : 1.0900 (-1.80%)
AIDX.TO : 1.56 (+0.65%)
VRSSF : 0.2795 (+9.61%)
VERS : 45.59 (+2.15%)
PATH : 14.24 (+4.09%)
LTRN : 3.08 (+4.41%)
Author
8 Best Artificial Intelligence Stocks Under $10 MarketBeat - Fri Aug 18, 2023

If you want to get in on artificial intelligence (AI) but don’t want to spend a lot, why not consider artificial intelligence stocks under $10? Learn more.

C : 69.84 (+1.29%)
GME : 27.90 (+0.29%)
INTC : 24.50 (+0.25%)
LRCX : 72.64 (-0.67%)
LTRN : 3.08 (+4.41%)
MSFT : 417.00 (+1.00%)
MOVE : 3.44 (+8.18%)
NVDA : 141.95 (-3.22%)
TSLA : 352.56 (+3.80%)
AMD : 138.35 (+0.63%)
NIO : 4.84 (+2.98%)
NOTE : 0.9299 (+7.19%)
Lantern Pharma to Report First Quarter 2023 Operating & Financial Results on May 9, 2023 at 4:30 p.m. ET Business Wire - Tue May 2, 2023

Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biopharmaceutical company using its proprietary RADR ® artificial intelligence (AI) and machine learning (ML) platform to transform the cost, pace,...

LTRN : 3.08 (+4.41%)
Lantern Pharma Develops Top-Ranked AI Algorithms to Predict the Blood-Brain-Barrier Permeability of Any Compound Business Wire - Tue May 2, 2023

Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biopharmaceutical company using its proprietary RADR ® artificial intelligence ("AI") and machine learning (“ML”) platform to transform the cost,...

LTRN : 3.08 (+4.41%)
Lantern Pharma Receives Notice of Allowance for Composition of Matter Patent Covering Drug Candidate LP-284 Business Wire - Thu Apr 13, 2023

Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biopharmaceutical company using its proprietary RADR ® artificial intelligence ("AI") and machine learning (“ML”) platform to transform the cost,...

LTRN : 3.08 (+4.41%)
Lantern Pharma Announces First Patient Dosed in the Phase 2 Study, Harmonic™, for LP-300 in Never Smokers with Advanced Non-Small Cell Lung Cancer Business Wire - Tue Mar 28, 2023

Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biopharmaceutical company using its proprietary RADR ® artificial intelligence ("AI") and machine learning (“ML”) platform to transform the cost,...

LTRN : 3.08 (+4.41%)

Barchart Exclusives

3 High-Yielding Dividend Kings to Boost Your Income in 2025 and Beyond Barchart - Fri Nov 22, 6:00PM CST
These three high-quality companies are currently on sale, offering elevated yields that appeal to dividend growth investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot